EUVIMEDEUVIMED entdecken
Crossref

TRPC3 and TRPC6 as molecular mediators of resistant hypertension and cardiac fibrosis: a new therapeutic frontier

Shobana Kumar, Kayatri Govindaraju, Sharifah Zamiah Syed Abdul Kadir, Abu Bakar Abdul Majeed, Amira Hajirah Abd Jamil, Nusaibah Abdul Rahim

Arterial Hypertension · 2025

DOI: 10.5603/ah.108127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arterial Hypertension, 2025. Verfasst von Shobana Kumar und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kumar, S., Govindaraju, K., Kadir, S. Z. S. A., Majeed, A. B. A., Jamil, A. H. A., & Rahim, N. A. (2025). TRPC3 and TRPC6 as molecular mediators of resistant hypertension and cardiac fibrosis: a new therapeutic frontier. Arterial Hypertension. https://doi.org/10.5603/ah.108127

Vancouver

Kumar S, Govindaraju K, Kadir SZSA, Majeed ABA, Jamil AHA, Rahim NA. TRPC3 and TRPC6 as molecular mediators of resistant hypertension and cardiac fibrosis: a new therapeutic frontier. Arterial Hypertension. 2025. doi:10.5603/ah.108127

BibTeX
@article{Kumar2025,
  author = {Kumar, Shobana and Govindaraju, Kayatri and Kadir, Sharifah Zamiah Syed Abdul and Majeed, Abu Bakar Abdul and Jamil, Amira Hajirah Abd and Rahim, Nusaibah Abdul},
  title = {TRPC3 and TRPC6 as molecular mediators of resistant hypertension and cardiac fibrosis: a new therapeutic frontier},
  journal = {Arterial Hypertension},
  year = {2025},
  doi = {10.5603/ah.108127}
}
Kostenlos starten →